Apriglim-MF 1 Tablet SR
Apriglim-MF 1 Tablet SR should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
Apriglim-MF 1 Tablet SR
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Apriglim-MF 1 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Apriglim-MF 1 Tablet SR should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems, and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
The most common side effect of Apriglim-MF 1 Tablet SR is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking, and know how to deal with it. To prevent this, it’s important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.
03How It Works
Apriglim-MF 1 Tablet SR is an antidiabetic medication. It works by increasing the amount of insulin released by the pancreas in order to lower blood glucose.
04What If You Miss A Dose?
If you miss a dose of Apriglim-MF 1 Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
05Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Loss of appetite
Abdominal pain
Diarrhea
Taste change
Vomiting
Nausea
06Safety Information
Alcohol:UNSAFE
It is unsafe to consume alcohol with Apriglim-MF 1 Tablet SR.
Pregnancy:CONSULT YOUR DOCTOR
Apriglim-MF 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:SAFE IF PRESCRIBED
Apriglim-MF 1 Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving:CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney:CAUTION
Apriglim-MF 1 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Apriglim-MF 1 Tablet SR may be needed. Please consult your doctor.Use of Apriglim-MF 1 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver:CAUTION
Apriglim-MF 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Apriglim-MF 1 Tablet SR may be needed. Please consult your doctor.Apriglim-MF 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
07Drug Tips
Glimepiride helps decrease high blood sugar level and avoid long-term complications of diabetes.
Take it shortly before or with the first main meal of the day (usually breakfast). Avoid skipping meals.
Exercise regularly, eat a healthy diet and take your other diabetes medicines (if prescribed) alongside.
Monitor your blood sugar level regularly while you are taking this medicine.
Be careful while driving or operating machinery until you know how Glimepiride affects you.
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor and anxiety.
Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms, such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
References
Sources and references
Glimepiride + Metformin. Karachi, Pakistan: Sanofi-Aventis Pakistan Ltd. view
Metformin Hydrochloride Prolonged Release & Glimepiride Tablets I.P. Ankleshwar: Sanofi India Limited; 2018. view
Glimepiride. Bridgewater, New Jersey: Sanofi-Aventis U.S. LLC.; 2009. view
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. view
